SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (218)2/5/1999 5:17:00 PM
From: DanZ  Read Replies (2) of 5582
 
Mike,

I agree completely with your message. This was just my point the other day when I said I buy cold remedies without requiring that the results of some study be posted on the shelf next to the product. I read the label and if it says "cuts the duration of the common cold", I will try it. If it doesn't work, I just won't buy it again. Like you say, this isn't rocket science LOL.

By the time the study results for Zicam are published in a medical journal, if at all, the price of GUMM will be significantly higher if Zicam wins in the marketplace. I agree with Bengalus that publication would provide free advertising, but the only other use for it would be in Zicam's advertising campaign. It would be nice to say, "as published in the NEJM, Zicam was shown to cut the duration and symptoms of the common cold to 1.5 days"...blah blah blah. Other than that, I think publication is a nonissue.

Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News